Unlock the power of Scientific AI
AI requires large scale, liquid, and well-engineered data sets to produce transformational outcomes, and yet every single data silo in your organization—ELN, LIMS, instruments, sensors—inhibits data scale, liquidity, and requisite AI-data design.
Leverage the Tetra Scientific Data and AI Cloud and build AI data workflows that accelerate the speed and increase the efficiency of your scientific decision-making.
Join the Scientific AI Revolution.
Get the missing piece of the puzzle
You need engineered data and a deep understanding of the scientific outcomes to fuel Scientific AI.
Get help from TetraScience experts who have demonstrable expertise in scientific data, workflows, and use cases. Complete the puzzle and unleash the power of your scientific data.
.svg)
Unique approach to Scientific AI
Data replatforming
Provide access to large-scale, liquid, and high-quality data required for AI that traditionally is not available to data scientists.
Data engineering
Embed domain knowledge into your scientific data through science-enriched taxonomies and ontologies.
Scientific validation
Trust your predictions with scientific explanations and comprehensible process steps, removing “black-box” models.
Continuous improvement
Improve your models through continuous model re-validation, re-training, and scientist interaction (human-in-the-loop).
Build a high-throughput Scientific AI Factory
Generate AI-based scientific outcomes at a high pace with our Scientific AI Factory model, enabled by the Tetra Scientific Data and AI Cloud.
Rapidly prototype Scientific AI outcomes through a collaboration with your internal AI and data science teams and Tetra Sciborgs.
Easily prioritize and productize final scientific AI outcomes.
.svg)
Scientific AI use cases
Scientific AI is bringing unprecedented value to life sciences across the value chain. Here are three customer examples:
Single parameter IC50 assay optimization—ML-guided concentration sampling reducing number of sampling points
Modeling of in-vitro ADME (QSAR) to predict interactions between samples and drug transporter/drug metabolizing enzyme
Plate reader data
Assay data from ELN
Well configuration
Reagent information
Molecular structure
Omics data
29% reduction of experiments
Faster drug discovery through continuous feedback loops combining the virtual (cheminformatics) and real (ADME tests)
Viable cell density
Glycosylation
Titer
Aggregation
Cell viability
Charge variants
Instrument & sensor data
Raw material characterization
Mechanistic understanding
8x reduction of bioreactor runs per study
In silico prediction to suggest new media mixtures
Prediction of deviations
AI-assisted root cause analysis
Instrument data
Audit trails
Out of trend reports
80% reduced number of deviations
90% faster investigation closure times
200% boost in lab productivity
ADME-Tox studies in drug discovery
Single parameter IC50 assay optimization - ML-guided concentration sampling reducing number of sampling points
Modeling of in-vitro ADME (QSAR) to predict interactions between samples and drug transporter/ drug metabolizing enzyme
Plate reader data
Assay data from ELN
Well configuration
Reagent information
Molecular structure
OMICS data
29% reduction of experiments
Faster drug discovery through continuous feedback loops combining the virtual (cheminformatics) and real (ADME tests)
AI for upstream bioprocess optimization
Viable cell density
Glycosylation
Titer
Aggregation
Cell viability
Charge variants
Instrument & sensor data
Raw material characterization
Mechanistic understanding
80 to 10 reduction of bioreactor runs per study
In silico prediction to suggest new media mixtures
AI for digital quality control
Prediction of deviations
AI-assisted root cause analysis
Instrument data
Audit trails
Out of trend reports
Out of trend reports
80%reduced number of deviations
90% faster investigation closure times
200% boost in lab productivity
Benefit from AI in every stage of the pharma value chain
Research
Improve target discovery by mining diverse data sets. Increase the speed and accuracy of in silico molecule screening. Explore a broader chemical space to aid de novo design. Uncover new targets for known drugs by modeling drug and protein interactions.
Development
Improve accuracy of predicting how drugs will behave in human subjects, eliminating unfavorable candidates earlier in development. Accelerate formulation development by rapidly probing a large parameter space and identifying optimal formulations to test.
Manufacturing and QC
Continuously monitor production lines and anticipate process deviations. Minimize failures by tracking instrument wear patterns and identifying anomalies before they become problems. Enhance QC by preemptively flagging and addressing out-of-spec results.
